Inventiva S.A.

Biotechnology • Healthcare • Daix, France • IVEVF (PNK)

Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and internationally. The company develops Lanifibranor, a novel pan-peroxisome proliferator-activated receptor agonist that is in the NATiV3 Phase 3 clinical trial to treat adult patients with MASH; and Odiparcil for the treatment of patients with mucopolysaccharidoses. It also develops TGF-ß, a pre-clinical program for the treatment of idiopathic pulmonary fibrosis. The company was incorporated in 2011 and is headquartered in Daix, France.

33 3 80 44 75 00 50 rue de Dijon, France

Stock Performance (90 Days)

Data through Dec 26, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

This is Why Wall Street is Bullish on Inventiva S.A. (IVA) - Yahoo Finance

Yahoo Finance • Dec 18

Moving Averages: How Inventiva SA 6IV stock correlates with oil markets - 2025 Technical Patterns & Daily Growth Stock Tips - moha.gov.vn

moha.gov.vn • Jan 5

Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat

MarketBeat • Dec 30

Piper Sandler reiterates Overweight rating on Inventiva stock ahead of key trial - Investing.com

Investing.com • Oct 10

Why Inventiva S.A. Depositary Receipt stock is favored by top institutions - Global Market Influence & Build Diversified Portfolios With Ease - bollywoodhelpline.com

bollywoodhelpline.com • Jan 1

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has Inventiva S.A. had layoffs?

No layoff events have been recorded for Inventiva S.A. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does Inventiva S.A. have?

Inventiva S.A. has approximately 84 employees.

What industry is Inventiva S.A. in?

Inventiva S.A. operates in the Biotechnology industry, within the Healthcare sector.

Is Inventiva S.A. a publicly traded company?

Yes, Inventiva S.A. is publicly traded under the ticker symbol IVEVF on the PNK. The company has a market capitalization of approximately $0.85 billion.

Where is Inventiva S.A. headquartered?

Inventiva S.A. is headquartered in Daix, France at 50 rue de Dijon, France.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.